Immunohistochemistry Expertise QualTek specializes in expert immunohistochemistry services with a track record of over 1,500 projects, offering potential for partnerships in drug development, biomarker discovery, and companion diagnostics.

GLP and CAP/CLIA Dual GLP-capable laboratories in Newtown and Santa Barbara, with CAP/CLIA certification in California, signaling high-quality, regulated capabilities suitable for pharmaceutical clients requiring compliant data and testing.

Niche to Pharma Deep integration of IHC data across basic research to clinical testing positions QualTek to support end-to-end drug development programs and enable data-driven decision-making for sponsors.

Growth-Ready Revenue Current revenue range indicates a small-to-moderate scale operation with room to expand services, geographic reach, and capacity to take on larger pharma collaborations or add-on services.

Strategic Partnerships Opportunity to align with larger contract research organizations or mid-sized biotech firms seeking specialized IHC capabilities, automation heritage, and data integration for companion diagnostics.